INNOVACAP · Concall Summary
INNOVA CAPTAB LIMITED
Innova Captab Limited reported strong financial performance for Q1 FY27, achieving a 34% year-on-year growth in revenue and a 33% increase in EBITDA. Management highlighted the strength of their diversified business model and disciplined execution, which contributed to sustained customer traction in both the CDMO and branded generic segments. The CDMO business generated INR328 crores in revenue, reflecting a 32% year-on-year growth, while the branded generic business reported INR142 crores, marking a 39% increase. Management emphasized their commitment to operational excellence and expanding their product portfolio. The earnings call also addressed questions regarding capacity utilization, with the Jammu facility operating at 25-30% utilization and generating INR107 crores in revenue. Management maintained a goal of over 20% volume growth for the year, while also discussing the impact of API pricing and the importance of disciplined capital allocation.
Management emphasized strong growth and operational performance.
View source filing →Earlier concalls
- 2026-08-11 — Innova Captab Limited's investor presentation, dated August 11, 2026, provided an overview of the company's financial pe…
- 2026-05-14 — Innova Captab Limited reported its highest annual performance for FY '26, with revenue reaching INR 1,630 crores, a 31% …
- 2026-05-07 — Innova Captab Limited's investor presentation detailed the company's financial results for the quarter and fiscal year e…
See INNOVACAP's full Research Pro page — annual report summary, insider trades, promoter pledge trend, options positioning and Ask-RedixFi AI.
Sign up free